Positive results for anifrolumab in phase III SLE trial

被引：6
|
作者：
Onuora, Sarah
机构：
[1] Nature Reviews Rheumatology,
来源：
NATURE REVIEWS RHEUMATOLOGY | 2020年 / 16卷 / 03期
关键词：
D O I：
10.1038/s41584-020-0384-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [1] Positive results for anifrolumab in phase III SLE trial
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 125 - 125
  • [2] Anifrolumab for SLE
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E134 - E134
  • [3] Positive results for GSK malaria vaccine in Phase III trial
    Riedmann, Eva M.
    HUMAN VACCINES, 2011, 7 (12): : 1246 - 1246
  • [4] Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
    Tummala, Raj
    Abreu, Gabriel
    Pineda, Lilia
    Michaels, M. Alex
    Kalyani, Rubana N.
    Furie, Richard A.
    Morand, Eric F.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [5] Anifrolumab bei SLE
    rheuma plus, 2021, 20 (4) : 142 - 142
  • [6] Positive Phase III trial results of Benlysta™ for systemic lupus erythematosus
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (05) : 495 - 495
  • [7] Positive phase III trial results reported by Genelabs Technologies for lupus treatment
    不详
    DRUG NEWS & PERSPECTIVES, 2000, 13 (01) : 18 - 18
  • [8] Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials
    Bruce, Ian N.
    Furie, Richard A.
    Morand, Eric F.
    Manzi, Susan
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Merrill, Joan T.
    Puzio, Patricia
    Maho, Emmanuelle
    Kleoudis, Christi
    Albulescu, Marius
    Hultquist, Micki
    Tummala, Raj
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 962 - 969
  • [9] Sertindole improves both the positive and negative symptoms of schizophrenia:: Results of a phase III trial
    Hale, A
    Azorin, JM
    Kasper, S
    Maier, W
    Syvälahti, E
    Van der Burght, M
    Sloth-Nielsen, M
    Wehnert, A
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2000, 4 (01) : 55 - 62
  • [10] Alteration of Vascular Inflammatory Markers in SLE By Anifrolumab in the Phase IIb Muse Study
    Casey, K. A.
    White, W. I.
    Seto, Nickie L.
    Playford, Martin
    Smith, M. A.
    Carlucci, P.
    Yu, B.
    Wang, L.
    Illei, G.
    Mehta, Nehal
    Kaplan, Mariana J.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345